Press Releases

WAT Medical Enterprise achieves a major milestone: HeadaTerm 2 receives the OTC clearance from the U.S. Food and Drug Administration (FDA), making it one of the only wearable anti-migraine devices that is available without a prescription in the U.S. Using neuromodulation technology, HeadaTerm 2 releases targeted electrical impulses to increase pain tolerance of its users. It is FDA-cleared for the preventative treatment of migraine headaches. The device has been clini

Viome, a leading innovator of health technology and personalized health solutions, is partnering with Henry Schein to provide better access to Viome's Oral Health Pro™ With CancerDetect™.* Viome's laboratory-developed test* helps detect early biomarkers of oral and throat cancers, enhancing practitioners' ability to effectively harness the power of preventive care and improve patient outcomes. Henry Schein will be the first stop for clinicians who want t

RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, fixed-site outpatient diagnostic imaging services through a network of 366 owned and/or operated outpatient imaging centers, announced today that it established a new joint venture in March with Providence Health System (“Providence”). The new joint venture, Tri Valley Imaging Group, was established in conjunction with RadNet contributing four California imaging centers – two centers in

Qualitas Dental Partners proudly announces its expansion into central Rhode Island, furthering its mission to deliver unparalleled patient care across the region. The four practices joining Qualitas are leaders in their market and represent a diverse range of dental specialties and services, including general dentistry, oral surgery, orthodontics, and endodontics. These industry leaders join a partnership of like-minded providers intent on ensuring continuity of care

Olympus announced today that it has been awarded a contract for its advanced energy portfolio by Provista Inc. This new, nationwide agreement provides Provista members with negotiated pricing for Olympus® energy products, including the POWERSEAL™ sealer/divider, the SONICBEAT™ ultrasonic portfolio and THUNDERBEAT™ hybrid energy portfolio. The multi-year agreement was effective as of July 1, 20

XtalPi Inc., a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking medicine and innovative materials, announced today the launch of its proprietary comprehensive solid form discovery and selection platform, XtalGazer. This advanced platform aims to significantly improve the polymorph selection process for the pharmaceutical industry by integrating AI- and automation-powered experimental and computational approac

Abridge and Sutter Health announced they will make Abridge’s generative AI platform for clinical documentation available to groups of its physicians across California. Sutter Health expects the broad deployment to improve patients’ experiences by helping support more focused face-time with clinicians. The large not-for-profit, integrated health system sees innovation as a way to transform the entire healthcare landscape and appreciates fellow innovators focused on t

NTT Corporation (NTT) and Olympus Corporation (Olympus) today announce that the two companies have jointly begun a demonstration experiment of a cloud endoscopy system that enables image processing on the cloud. This cloud endoscopy system utilizes Olympus' advanced technology for endoscopes to perform image processing, which has been conventionally processed within the endoscopic equipment,  on a remote cloud. This has been difficult to achieve with conventional network te

HeartFlow, Inc., the leader in AI-driven healthcare technology, today announced the launch of the DECIDE Registry, the largest prospective registry of its kind, with the first site initiated, Cone Health Care. The registry will collect multi-site, real-world information on how the Plaque Analysis product provides enhanced patient insights, empowering physicians and helping to inform their medical management decisions for patients with suspected coronary artery disease (CAD). HeartFlow Plaque

Center For Sight, A US Eye Company, one of the nation’s leading ophthalmology practices, has performed the first iDoseTR implant surgery in the state of Florida since the device was approved by the Food and Drug Administration in December, 2023. The iDoseTR implant, manufactured by Glaukos Corporation, is a sustained release ophthalmic implant that is surgically placed in the eye. The device consistently distributes a travoprost formula to help reduce intraocular pressure in patients wi